TELA
Stock Details
TELA is TELA Bio, Inc.'s stock. Stock exchange NasdaqGM (Currency USD). Average price in 50 days is 5.30$. Average daily volumn in 3 months 152.06k. Market cap 134.13M
Stock symbol : TELA. Exchange : NasdaqGM. Currency : USD Lastest price : 5.44$. Total volume : 122.62k. Market state CLOSED Click reload if you want to check the lastest price on market!!!
TELA Bio, Inc. (TELA)
Last Price
5.44$Change
0.26Volume
122.62k
| Previous Close | 5.18 |
| Open | 5.17 |
| Day Range | 5.17-5.44 |
| Bid | 5.39 x 200 |
| Ask | 5.47 x 100 |
| Volume | 122.62k |
| Average Volume | 152.06k |
| Market Cap | 134.13M |
| Beta | 1.04 |
| 52 Week Range | 4.24-10.84 |
| Trailing P/E | N/A |
| Foward P/E | -4.46 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex ... for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Market Cap:
134.13MRevenue:
58.45M
News about "TELA Bio, Inc."
TELA Bio, Inc. (TELA)
Source from : Yahoo Finance - 2 years ago
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions ...See details»
TELA Bio Inc Ordinary Shares TELA
Source from : Morningstar - 5 days ago
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...See details»
TELA Bio Stock (NASDAQ:TELA), Quotes and News Summary
Source from : Benzinga.com - 3 years ago
TELA Bio (NASDAQ: TELA) shares are trading lower ... His Love For Jet-Setting At Odds With Tesla's Climate Stance? Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers ...See details»
TELA Bio, Inc. Common Stock (TELA)
Source from : Nasdaq - 4 years ago
Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by ...See details»
Tela Bio (TELA) Earnings Dates & Reports
Source from : Investing - 20 days ago
View upcoming earnings forecasts and in-depth analysis of company forecasts.See details»
TELA Bio, Inc.: TELA Bio Appoints Greg Firestone as Chief Commercial Officer
Source from : Finanznachrichten - 1 month ago
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions ...See details»
CABA Cabaletta Bio, Inc.
Source from : Seeking Alpha - 1 days ago
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases.See details»
TSVT 2seventy bio, Inc.
Source from : Seeking Alpha - 2 days ago
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline ...See details»
MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results
Source from : Finanznachrichten - 1 month ago
as well as the $5 million cash payment associated with our agreement with TELA Bio, Inc., paving the way for our exclusive manufacturing and supply agreement with Regenity Biosciences. A replay of ...See details»
Rezolute, Inc.
Source from : CNN - 10 month ago
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products include RZ358-Phase 2 ...See details»
Vor Biopharma, Inc.
Source from : CNN - 6 month ago
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to ...See details»
MiMedx Group, Inc.
Source from : CNN - 4 month ago
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn ...See details»
TELA Bio Inc Ordinary Shares
Source from : Morningstar - 17 days ago
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...See details»
TELA Bio, Inc. Common Stock (TELA)
Source from : Nasdaq - 1 year ago
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...See details»